1.
Clin Case Rep
; 9(1): 395-398, 2021 Jan.
Article
in English
| MEDLINE
| ID: mdl-33362928
ABSTRACT
COVID-19 in the setting of SGLT2 inhibitor use may precipitate euglycemic DKA separate from known acute viral illness and dehydration precipitants. There should be consideration of proactive discontinuation of these medications in these patients.
